Biogen Inc
General ticker "BIIB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $22.7B
Biogen Inc does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 1.4%: low 144.86$, high 148.85$
Factors to consider:
- Company included in S&P500 list
- Current price 28.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [207.80$, 312.53$]
- 2024-12-30 to 2025-12-30 estimated range: [202.14$, 310.49$]
Financial Metrics affecting the BIIB estimates:
- Positive: Non-GAAP EPS, $ of 14.73 > 2.29
- Positive: 9.05 < Operating profit margin, % of 13.62
- Negative: Interest expense per share, $ of 1.71 > 0.74
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term BIIB quotes
Long-term BIIB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $10,981.70MM | $10,994.40MM | $9,835.60MM |
| Operating Expenses | $8,141.00MM | $7,402.60MM | $7,738.30MM |
| Operating Income | $2,840.70MM | $3,591.80MM | $2,097.30MM |
| Non-Operating Income | $-1,095.50MM | $0.00MM | $-800.50MM |
| Interest Expense | $253.60MM | $246.60MM | $246.90MM |
| R&D Expense | $2,501.20MM | $2,231.10MM | $2,462.00MM |
| Income(Loss) | $1,745.20MM | $3,591.80MM | $1,296.80MM |
| Taxes | $52.50MM | $632.80MM | $135.30MM |
| Other Income(Loss) | $34.90MM | $2.60MM | $0.00MM |
| Profit(Loss) | $1,727.60MM | $2,961.60MM | $1,161.50MM |
| Stockholders Equity | $10,896.20MM | $13,397.90MM | $14,799.40MM |
| Inventory | $1,351.50MM | $1,344.40MM | $2,527.40MM |
| Assets | $23,877.30MM | $24,554.10MM | $26,844.80MM |
| Operating Cash Flow | $3,639.90MM | $1,384.30MM | $1,547.20MM |
| Capital expenditure | $294.90MM | $243.20MM | $311.40MM |
| Investing Cash Flow | $-563.70MM | $1,576.60MM | $-4,101.00MM |
| Financing Cash Flow | $-2,086.20MM | $-1,759.70MM | $149.30MM |
| Earnings Per Share* | $10.44 | $20.97 | $8.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.